Literature DB >> 18302067

Preliminary report on elective preterm delivery at 34 weeks and primary abdominal closure for the management of gastroschisis.

A Serra1, G Fitze, G Kamin, J Dinger, I R König, D Roesner.   

Abstract

INTRODUCTION: We aimed to critically evaluate elective preterm delivery and immediate abdominal wall closure and other techniques for the management of gastroschisis, hypothesizing that the advantages of an elective preterm delivery outweigh possible complications related to prematurity at birth. PATIENTS AND METHODS: 13 gastroschisis patients were enrolled in the elective preterm delivery program (Group 1) since 1999. Patients were delivered by cesarean section in the 34th gestational week, with immediate primary closure of the defect. Data regarding parameters at and after birth were compared with a historical control group of 10 patients conventionally managed for gastroschisis in a similar period (1994 - 1999) (Group 2). The primary endpoints of this study were the initiation of oral feeding and the length of hospital stay.
RESULTS: There was a significantly faster initiation of oral feeding (p = 0.0012) and a shorter hospital stay (p = 0.0160) in Group 1. The postoperative outcome was excellent in all patients. Acute and late complications were fewer and less severe in Group 1 and none were related to prematurity.
CONCLUSIONS: Elective preterm delivery appears to be an effective method for the management of gastroschisis, and a method whose advantages thus far have outweighed the possible complications due to prematurity.

Entities:  

Mesh:

Year:  2008        PMID: 18302067     DOI: 10.1055/s-2007-965744

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  8 in total

1.  Outcomes in infants with prenatally diagnosed gastroschisis and planned preterm delivery.

Authors:  Carmen Mesas Burgos; Anna Svenningsson; Jenny Hammarqvist Vejde; Tina Granholm; Peter Conner
Journal:  Pediatr Surg Int       Date:  2015-09-23       Impact factor: 1.827

2.  Scheduled preterm delivery for gastroschisis improves postoperative outcome.

Authors:  Thomas Gelas; Daniela Gorduza; Simone Devonec; Pascal Gaucherand; Esther Downham; Olivier Claris; Rémi Dubois
Journal:  Pediatr Surg Int       Date:  2008-07-31       Impact factor: 1.827

3.  The influence of gestational age, mode of delivery and abdominal wall closure method on the surgical outcome of neonates with uncomplicated gastroschisis.

Authors:  Maria V Fraga; Pablo Laje; William H Peranteau; Holly L Hedrick; Nahla Khalek; Juliana S Gebb; Julie S Moldenhauer; Mark P Johnson; Alan W Flake; N Scott Adzick
Journal:  Pediatr Surg Int       Date:  2018-02-07       Impact factor: 1.827

4.  Outcome and management in neonates with gastroschisis in the third millennium-a single-centre observational study.

Authors:  Lotta Räsänen; Helene Engstrand Lilja
Journal:  Eur J Pediatr       Date:  2022-02-28       Impact factor: 3.860

5.  Mortality from gastroschisis in the state of Rio de Janeiro: a 10-year series.

Authors:  Camilla Ferreira Catarino Barreiros; Maria Auxiliadora de Souza Mendes Gomes; Saint Clair Dos Santos Gomes Júnior
Journal:  Rev Saude Publica       Date:  2020-06-12       Impact factor: 2.106

6.  Does meconium contaminated amniotic fluid affect intestinal wall thickness and functional outcome in patients with anterior abdominal wall defects?

Authors:  Melanie Kapapa; Teresa Rieg; Alexandre Serra
Journal:  Afr J Paediatr Surg       Date:  2022 Jan-Mar

7.  Effect of gestational age at birth on neonatal outcomes in gastroschisis.

Authors:  Helen Carnaghan; David Baud; Eveline Lapidus-Krol; Greg Ryan; Prakesh S Shah; Agostino Pierro; Simon Eaton
Journal:  J Pediatr Surg       Date:  2016-02-11       Impact factor: 2.545

8.  Umbilical hernia following gastroschisis closure: a common event?

Authors:  L G C Tullie; G M Bough; A Shalaby; E M Kiely; J I Curry; A Pierro; P De Coppi; K M K Cross
Journal:  Pediatr Surg Int       Date:  2016-06-25       Impact factor: 1.827

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.